TransEnterix Announces Sinai Health System in Chicago to Initiate Program with the Senhance Surgical System
“Our team is excited that
The Senhance System is the first new abdominal robotic surgery platform to receive FDA clearance since 2000. It is the first and only digital laparoscopic surgical platform designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation including, 3 mm microlaparoscopic instruments, eye sensing camera control and reusable standard instruments to help maintain per-procedure costs similar to traditional laparoscopy. In
“We chose the Senhance Surgical System because it offers unique capabilities in adding robotics to our surgical program,” said Dr.
“As a health system, we seek to offer the best possible care utilizing the latest technology to all the patients we serve in our community, and we are proud to be the first hospital in
This press release includes statements relating to the Senhance System and the